CLINICAL_TRIALS
trial_result
· 2017-02-24
Clinical Trial Update: High Dose Nimodipine Treatment Adjunct - 1 [Phase 2]
Summary
This document reports an update on a Phase 2 trial of high-dose nimodipine as an adjunct treatment for cocaine-related disorders. The study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED